home / stock / lndc / lndc short
Short Information | Landec Corporation (NASDAQ:LNDC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 144,427 |
Total Actual Volume | 1,364,694 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 7,221 |
Average Short Percentage | 12.12% |
Is there a LNDC Short Squeeze or Breakout about to happen?
See the LNDC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-14-2022 | $9.01 | $8.76 | $9.01 | $8.71 | 72,075 | 6,251 | 8.67% |
11-11-2022 | $9.12 | $9.08 | $9.12 | $8.94 | 57,298 | 5,055 | 8.82% |
11-10-2022 | $9.01 | $9.03 | $9.08 | $8.84 | 57,039 | 4,160 | 7.29% |
11-09-2022 | $8.91 | $8.65 | $8.95 | $8.57 | 22,835 | 1,649 | 7.22% |
11-08-2022 | $9.05 | $8.95 | $9.06 | $8.925 | 32,074 | 5,235 | 16.32% |
11-07-2022 | $9.03 | $9.03 | $9.18 | $8.95 | 29,440 | 5,274 | 17.91% |
11-04-2022 | $9.26 | $9.05 | $9.26 | $8.99 | 36,456 | 4,069 | 11.16% |
11-03-2022 | $9 | $9.13 | $9.25 | $8.97 | 44,025 | 4,524 | 10.28% |
11-02-2022 | $9.56 | $9.16 | $9.665 | $9.12 | 47,978 | 3,147 | 6.56% |
11-01-2022 | $9.85 | $9.68 | $9.99 | $9.65 | 48,705 | 6,021 | 12.36% |
10-31-2022 | $9.86 | $9.95 | $10.5 | $9.8433 | 150,454 | 37,351 | 24.83% |
10-28-2022 | $9.27 | $9.91 | $10 | $9.21 | 71,251 | 9,572 | 13.43% |
10-27-2022 | $8.74 | $9.2 | $9.35 | $8.74 | 73,196 | 5,092 | 6.96% |
10-26-2022 | $8.53 | $8.56 | $8.76 | $8.5 | 48,666 | 7,323 | 15.05% |
10-25-2022 | $8.13 | $8.48 | $8.66 | $8.13 | 56,287 | 7,714 | 13.7% |
10-24-2022 | $8.08 | $8.12 | $8.16 | $8.06 | 334,656 | 4,913 | 1.47% |
10-21-2022 | $8.16 | $8.09 | $8.28 | $8.07 | 43,340 | 5,238 | 12.09% |
10-20-2022 | $8.14 | $8.09 | $8.15 | $8 | 36,878 | 7,045 | 19.1% |
10-19-2022 | $8.3 | $8.06 | $8.3 | $8 | 53,114 | 6,587 | 12.4% |
10-18-2022 | $8.4 | $8.28 | $8.61 | $8.23 | 48,927 | 8,207 | 16.77% |
News, Short Squeeze, Breakout and More Instantly...
Year-to-date Results Consistent with Prior Expectations; Experiencing Fiscal Second Half Lift Provides Fiscal 2024 Full Year Guidance Commercial Momentum Continues within Development Portfolio Capacity Expansion Projects Progressing CHASKA, Minn., April 01, 2024 (G...
CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced today that Ernst & Young LLP, th...
Appoints Paul Josephs, an executive with 25 years of CDMO experience as CEO, to succeed current CEO James Hall following his retirement Announces changes to its Board of Directors, appoints new Board Chair CHASKA, Minn., March 20, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc....